Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net loss	$ (2,746,267)	$ (2,061,078)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	11,976	8,410
Stock option compensation expense	49,185	100,615
Share-based compensation - common stock	4,038	7,655
Bad debt expense	79,500	5,000
Debt discount amortization	185,525	102,710
Noncash finance charges	18,434	13,775
Unrealized loss on derivative instruments	79,351	41,137
Loss on conversion of notes	48,788
Loss on settlement of note and warrant	132,301
Changes in assets and liabilities:
Receivables	(171,883)	149,707
Prepaid expenses and other current assets	(50,888)	118,588
Inventory	150,000	60,000
Accounts payable, accrued expenses and other liabilities	1,417,832	182,745
Deferred revenue	13,287	(1,600)
Net cash used in operating activities	(778,821)	(1,272,336)
Cash flows from investing activities:
Purchase of property and equipment	(47,688)
Cash used in investing activities	(47,688)
Cash flows from financing activities:
Proceeds from note payable	120,000	1,288,000
Repayment of note and warrant settlement	(242,000)
Proceeds from common stock and warrants	892,000
Net cash provided by financing activities	770,000	1,288,000
Net increase (decrease) in cash	(56,509)	15,664
Cash at beginning of period	57,009	74,322
Cash at end of period	$ 500	$ 89,986